Vontobel Holding’s Aerie Pharmaceuticals AERI Stock Holding History

Vontobel Holding’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-46,655	Closed	-$532K	–	1245
2021 Q3	$532K	Hold	46,655	–	–	﹤0.01%	774
2021 Q2	$747K	Buy	46,655 +6,655	+17%	+$114K	0.01%	668
2021 Q1	$715K	Hold	40,000	–	–	0.01%	589
2020 Q4	$540K	Buy	+40,000	New	+$483K	﹤0.01%	637

Other funds holding AERI

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Vontobel Holding's AERI Position: Q4 2021 in Review

Vontobel Holding sold out of Aerie Pharmaceuticals (AERI) in Q4 2021, closing a stake of 46,655 shares — an estimated $532K sold.

Vontobel Holding first reported a position in AERI in Q4 2020 and held it in 4 quarters. The position peaked at $747K in Q2 2021. 129 funds tracked by Wall St. Rank hold AERI as of Q4 2021.

Vontobel Holding reported no remaining Aerie Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Vontobel Holding sold 46,655 Aerie Pharmaceuticals shares in Q4 2021, an estimated $532K.
Vontobel Holding first reported a position in Aerie Pharmaceuticals in Q4 2020 and held it in 4 quarters.
Vontobel Holding's Aerie Pharmaceuticals position peaked at $747K in Q2 2021.
129 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2021.

Based on Vontobel Holding's 13F filing for Q4 2021, filed 10 Feb 2022.